ReviewBreast (Edinburgh, Scotland)2017
De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance.
Jamunarani Veeraraghavan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it